AI better than biopsy at assessing retroperitoneal sarcoma! Seminal work from The Royal Marsden NHS Foundation Trust & The ICR Christina Messiou team: authors.Elsevier.com/sd/article/S14… The Lancet Oncology

This The Royal Marsden NHS Foundation Trust and The ICR study found that an AI algorithm was far better than a biopsy at correctly grading the aggressiveness of sarcomas. These results look promising. We welcome any research that helps patients receive better treatment. theguardian.com/science/2023/o…

In the week of the AI Fringe AND the annual CTOS international sarcoma conference to see the potential benefits of AI on diagnosing sarcoma earlier Amani Arthur Paul Huang Lab The ICR

Professor Christina Messiou, Consultant Radiologist at The Royal Marsden: “This is the largest and most robust study to date that has successfully developed and tested an AI model aimed at improving the diagnosis and grading of retroperitoneal sarcoma using data from CT scans."

📢NEWS: Artificial intelligence could be twice as accurate as a biopsy at grading the aggressiveness of some #Sarcomas. The approach could help speed up diagnosis of these rare cancers. Read more about this research from the ICR and The Royal Marsden NHS Foundation Trust⬇️ icr.ac.uk/news-archive/a…

NEW: A retrospective multicohort analysis aims to develop and validate a CT-based radiomics classification model for the prediction of histological type and grade in retroperitoneal leiomyosarcoma and liposarcoma. #OA #OpenAccess thelancet.com/journals/lanon…

📰Our researchers suggest using #AI could help tailor treatment more accurately than a biopsy, and could also help doctors diagnose subtypes of #Sarcoma #Cancer faster. Read more in The Independent👇 independent.co.uk/news/health/in…

📢📚 Thrilled to share our recent #publication on #RetroperitonealSarcoma in the The Lancet Oncology. Go to the publication: eortc.org/bibliography/ Paul Huang Lab Mateusz Robby Emsley Christina Messiou Sharon V Paul Huang Lab #CancerResearch #ClinicalTrials #Oncology

"It's exciting to see #AI – which is trained to spot incredibly subtle signs that a #Cancer is aggressive – enable rapid diagnosis and classification of this rare type of #Sarcoma.'' - Paul Huang Lab Read more about this major breakthrough👇 icr.ac.uk/news-archive/a…

Less than 24h to go for the FREE Paediatric Emergencies 2023 streaming live on YouTube from 8am UK time tomorrow 9th of Nov > 20k streams of past conferences to date (up to 2K live) globally Fantastic lineup No need to register Link youtube.com/@PaediatricEme… Programme 👇 #PedsICU

The Scream of Gaza by Tunisian artist Omar Esstar. If you haven't felt this deep in your soul for the last 80 days, check your humanity.💔🇵🇸

Wael al-Dahdouh is back on Al Jazeera today. If he doesn't win the 2024 Pulitzer Prize, then that prize has no value for journalism whatsoever.

New year, new research announcement 🔬✨ We are proud to welcome 2024 with a brand-new research project by Dr Huang The ICR. Thanks to funding from Bone Cancer Research Trust, Little Princess Trust & Children’s Cancer and Leukaemia Group, he hopes to identify patients likely to respond to specific treatments. ow.ly/n0V950QqWlM

So, I had to evacuate for a lot of reasons you all know some of it but not all of it. Thank you all Pray for Gaza.

#Breathtaking premieres tonight 9.00 pm ⁦ITV⁩, from the memoir by ⁦Dr Rachel Clarke⁩. As a former junior hospital doctor, I couldn’t be prouder of cowriting this 3-part drama paying tribute to the untold sacrifices of #NHS staff. All episodes available now ITVX.

A special day yesterday! 🎉Thank you to my supervisors Christina Messiou and Paul Huang Lab and my wonderful colleagues for their endless support. And to my examiners for the excellent and insightful discussion.

Our new paper "Proteomic features of soft tissue sarcomas in adolescents and young adults (AYA)" is out in Communications Medicine! nature.com/articles/s4385… We analyse the proteomic profiles of AYA #sarcomas and compared them with those from older patients. What did we find out? A 🧵1/6

🚨Our latest paper evaluating #proteomic signatures with the Sarculator nomogram to predict high-risk #sarcoma patients is out in CancerMedicine! This is a wonderful collaboration with Sandro Pasquali Rosalba Miceli Alessandro Gronchi Istituto Tumori Read more here dx.doi.org/10.1002/cam4.7…

So privileged to have been a part of this special lab - full of inspiration, lessons and above all friendship. Will always hold a dear place in my heart!